Achieved key turnaround milestones, including $7M in cost reductions, decreased leverage, and refinancing of high-cost, inflexible debt. Established sales operations and analytics, positioning the company for its first significant period of organic growth in over 20 years.
Implemented financial processes to enhance discipline and improve ROIC. Launched an initiative, resulting in robust pricing models and the creation of a deal desk. Collaborated with commercial leaders on pricing strategies, generating over $1M in annual EBITDA.
Shortly after joining, developed a strategic action plan with multi-year financial goals following a comprehensive forensic assessment of the business and financials, and publicly committed to the plan for life science tools company.
Established cash management fundamentals, maintaining liquidity pre-recapitalization and avoiding covenant issues. Secured $1M+ in savings through vendor negotiations and tech-driven efficiencies in billing, banking, and insurance.
Led M&A strategy to enter post-acute markets, including a $180M acquisition of a national distributor with $6M+ in cost synergies, achieving 6x EBITDA multiples.
Acted as Interim CFO with expanded duties, including overseeing the integration of a major acquisition.